Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials (Q46817257)

25 December 2017

title

Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials (English)

1 reference

25 December 2017

author

Jonas Abrahamsson

2

1 reference

25 December 2017

Henrik Hasle

5

1 reference

25 December 2017

author name string

S O Lie

1

1 reference

25 December 2017

N Clausen

3

1 reference

25 December 2017

E Forestier

4

1 reference

25 December 2017

L Hovi

6

1 reference

25 December 2017

G Jonmundsson

7

1 reference

25 December 2017

L Mellander

8

1 reference

25 December 2017

M A Siimes

9

1 reference

25 December 2017

M Yssing

10

1 reference

25 December 2017

B Zeller

11

1 reference

25 December 2017

G Gustafsson

12

1 reference

25 December 2017

Nordic Society of Pediatric Hematology and Oncology (NOPHO)

13

1 reference

25 December 2017

AML Study Group

14

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

published in

Leukemia

1 reference

25 December 2017

volume

19

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

2090-2100

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403962

exact match

0 references

cites work

A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Onco

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

The role of allogeneic transplantation in high-risk acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Favorable impact of the t(9;11) in childhood acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Definition of a standard-risk group in children with AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

7 January 2021

Vitamin A and/or high-dose Ara-C in the maintenance of remission in acute myelogenous leukaemia in children?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

7 January 2021

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

7 January 2021

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

7 January 2021

Prognostic factors in infants with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

7 January 2021

Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

7 January 2021

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403962

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403962

1 reference

25 December 2017

release_5clnendj6bbh5bg3zpdtjzzfwu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5clnendj6bbh5bg3zpdtjzzfwu

24 November 2022

mapped directly with Wikidata item

PubMed ID

16304571

1 reference

25 December 2017